反応 #155329
ord-64f1f98f6e324a17a8329873ce2fb169
反応方程式
反応物
試薬
反応条件
後処理
- 1濃縮concentrated under reduced pressure
- 2workup.ADDITIONWater and ethyl acetate were added to the residue
- 3その他followed by separation
- 4洗浄The thus-obtained organic layer was washed with water
- 5濃縮concentrated under reduced pressure
- 6その他The residue was purified
- 7濃縮The purified product was concentrated under reduced pressure
- 8その他the residue was recrystallized from ethyl acetate
実験手順
4-(2-Aminoethyl)morpholine (217 mg, 1.7 mmol) was added to a DMF solution (10 ml) of [3-(4-methoxyphenyl)-4-oxo-10-propoxy-7,8-dihydro-4H,6H-5-oxa-1-aza-phenanthren-1-yl]acetic acid (580 mg, 1.39 mmol), 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU, 790 mg, 2.1 mmol) and triethylamine (5 ml). The mixture was stirred overnight at room temperature and then concentrated under reduced pressure. Water and ethyl acetate were added to the residue, followed by separation. The thus-obtained organic layer was washed with water and concentrated under reduced pressure. The residue was purified using silica gel column chromatography (dichloromethane:methanol=10:1). The purified product was concentrated under reduced pressure, and the residue was recrystallized from ethyl acetate, giving a pale brown powder of 2-[3-(4-methoxyphenyl)-4-oxo-10-propoxy-7,8-dihydro-4H,6H-5-oxa-1-aza-phenanthren-1-yl]-N-(2-morpholin-4-ylethyl)acetamide (115 mg, yield: 16%).